Urotensin-II regulates intracellular calcium in dissociated rat spinal cord neurons

被引:39
作者
Filipeanu, CM [1 ]
Brailoiu, E [1 ]
Le Dun, S [1 ]
Dun, NJ [1 ]
机构
[1] E Tennessee State Univ, James H Quillen Coll Med, Dept Pharmacol, Johnson City, TN 37614 USA
关键词
Ca2+]i; Ca2+ influx; protein kinase A; spinal neurons; urotensin-II;
D O I
10.1046/j.1471-4159.2002.01196.x
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Urotensin-II (U-II), a peptide with multiple vascular effects, is detected in cholinergic neurons of the rat brainstem and spinal cord. Here, the effects of U-II on [Ca2+](i) was examined in dissociated rat spinal cord neurons by fura 2 microfluorimetry. The neurons investigated were choline acetyltransferase-positive and had morphological features of motoneurons. U-II induced [Ca2+](i) increases in these neurons with a threshold of 10(-9) M, and a maximal effect at 10(-6) M with an estimated EC50 of 6.2x10(-9) M. The [Ca2+](i) increase induced by U-II was mainly caused by Ca2+ influx from extracellular space, as the response was markedly attenuated in a Ca2+-free medium. Omega-conotoxin GVIA (10(-7) M), a N-type Ca2+ channel blocker, largely inhibited these increases, whereas the P/Q Ca2+ channel blocker, omega-conotoxin GVIIC (10(-7) M) and the L-type Ca2+ channel blocker, verapamil (10(-5) M) had minimal effects. Down-regulation of protein kinase C by 4-alpha-phorbol 12-myristate 13-acetate (10(-6) M) or enzyme inhibition using the specific inhibitor bisindolylmaleimide I (10(-6) M) did not inhibit the observed effects. Similarly, inhibition of protein kinase G with KT5823 (10(-6) M) or Rp-8-pCPT-cGMPS (3x10(-5) M) did not modify U-II-induced [Ca2+](i) increases. In contrast, protein kinase A inhibitors KT5720 (10(-6) M) and Rp-cAMPS (3x10(-5) M) reduced the response to 25+/-3% and 42+/-8%, respectively. Present results demonstrate that U-II modulates [Ca2+](i) in rat spinal cord neurons via protein kinase A cascade.
引用
收藏
页码:879 / 884
页数:6
相关论文
共 38 条
[1]   Human urotensin-II is a potent vasoconstrictor and agonist for the orphan receptor GPR14 [J].
Ames, RS ;
Sarau, HM ;
Chambers, JK ;
Willette, RN ;
Alyar, NV ;
Romanic, AM ;
Louden, CS ;
Foley, JJ ;
Sauermelch, CF ;
Coatney, RW ;
Ao, ZH ;
Disa, J ;
Holmes, SD ;
Stadel, JM ;
Martin, JD ;
Liu, WS ;
Glover, GI ;
Wilson, S ;
McNulty, DE ;
Ellis, CE ;
Elshourbagy, NA ;
Shabon, U ;
Trill, JJ ;
Hay, DWP ;
Ohlstein, EH ;
Bergsma, DJ ;
Douglas, SA .
NATURE, 1999, 401 (6750) :282-286
[2]   P2Y receptors contribute to ATP-induced increases in intracellular calcium in differentiated but not undifferentiated PC12 cells [J].
Arslan, G ;
Catalin, CM ;
Irenius, E ;
Kull, B ;
Clementi, E ;
Allgaier, C ;
Erlinge, D ;
Fredholm, BB .
NEUROPHARMACOLOGY, 2000, 39 (03) :482-496
[3]   Human urotensin-II is an endothelium-dependent vasodilator in rat small arteries [J].
Bottrill, FE ;
Douglas, SA ;
Hiley, CR ;
White, R .
BRITISH JOURNAL OF PHARMACOLOGY, 2000, 130 (08) :1865-1870
[4]   Effects of human urotensin II in isolated vessels of various species;: comparison with other vasoactive agents [J].
Camarda, V ;
Rizzi, A ;
Calò, G ;
Gendron, G ;
Perron, SI ;
Kostenis, E ;
Zamboni, P ;
Mascoli, F ;
Regoli, D .
NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 2002, 365 (02) :141-149
[5]   Cloning, sequence analysis and tissue distribution of the mouse and rat urotensin II precursors [J].
Coulouarn, Y ;
Jégou, S ;
Tostivint, H ;
Vaudry, H ;
Lihrmann, I .
FEBS LETTERS, 1999, 457 (01) :28-32
[6]   Human urotensin-II, the most potent mammalian vasoconstrictor identified to date, as a therapeutic target for the management of cardiovascular disease [J].
Douglas, SA ;
Ohlstein, EH .
TRENDS IN CARDIOVASCULAR MEDICINE, 2000, 10 (06) :229-237
[7]   Human urotensin-II is a potent vasoactive peptide: Pharmacological characterization in the rat, mouse, dog and primate [J].
Douglas, SA ;
Ashton, DJ ;
Sauermelch, CF ;
Coatney, RW ;
Ohlstein, DH ;
Ruffolo, MR ;
Ohlstein, EH ;
Aiyar, NV ;
Willette, RN .
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 2000, 36 :S163-S166
[8]   Urotensin II-immunoreactivity in the brainstem and spinal cord of the rat [J].
Dun, SL ;
Brailoiu, GC ;
Yang, J ;
Chang, JK ;
Dun, NJ .
NEUROSCIENCE LETTERS, 2001, 305 (01) :9-12
[9]   Intracellular angiotensin II: from myth to reality? [J].
Filipeanu, CM ;
Henning, RH ;
Nelemans, SA ;
de Zeeuw, D .
JOURNAL OF THE RENIN-ANGIOTENSIN-ALDOSTERONE SYSTEM, 2001, 2 (04) :219-226
[10]   Regulation of [Ca2+]i homeostasis in MRP1 overexpressing cells [J].
Filipeanu, CM ;
Nelemans, A ;
Veldman, RJ ;
de Zeeuw, D ;
Kok, JW .
FEBS LETTERS, 2000, 474 (01) :107-110